OLIVIA NGUYEN: Open Payments
NPI 1801362108 · AVONDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,712 in 62 payments from 15 companies in 2025. Trend: 2023 $463 · 2024 $1,595 · 2025 $1,712
Food & beverage: $1,603Education: $109
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $414 |
| Janssen Biotech, Inc. | 13 | $335 |
| ABBVIE INC. | 12 | $200 |
| Janssen Scientific Affairs, LLC | 1 | $131 |
| Gilead Sciences, Inc. | 5 | $118 |
| Ardelyx, Inc. | 4 | $114 |
| QOL Medical, LLC | 3 | $101 |
| Aimmune Therapeutics, Inc. | 3 | $81 |
| Ipsen Biopharmaceuticals, Inc | 3 | $70 |
| PFIZER INC. | 2 | $43 |
Products named: TREMFYA, ENTYVIO, IBSRELA, Sucraid, ZENPEP, IQIRVO, RINVOQ, EOHILIA.
Industry payments across AZ — which companies pay providers there.
